Citigroup Maintains Neutral on GE HealthCare Techs, Raises Price Target to $75

Benzinga Newsdesk www.benzinga.com Positive 68.8%

Neg 0% Neu 0% Pos 68.8%

Citigroup analyst Joanne Wuensch maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $69 to $75.